For example, IL-1B (-511C > T) has been reported to be associated with the severity and progression of multiple sclerosis (MS), while the NLRC4 rs479333 G > C variant has shown beneficial effects by limiting disease progression and supporting response to treatment with INF-β [53]. Here, IL1B is linked to myeloid sarcoma.